KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $982.0 million.

  • Quest Diagnostics' Other Non-Current Liabilities rose 1021.32% to $982.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $982.0 million, marking a year-over-year increase of 1021.32%. This contributed to the annual value of $938.0 million for FY2024, which is 707.76% up from last year.
  • Latest data reveals that Quest Diagnostics reported Other Non-Current Liabilities of $982.0 million as of Q3 2025, which was up 1021.32% from $890.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year Other Non-Current Liabilities high stood at $982.0 million for Q3 2025, and its period low was $728.0 million during Q2 2022.
  • Its 5-year average for Other Non-Current Liabilities is $842.2 million, with a median of $817.0 million in 2024.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 1187.65% in 2022, then skyrocketed by 2376.37% in 2023.
  • Quarter analysis of 5 years shows Quest Diagnostics' Other Non-Current Liabilities stood at $792.0 million in 2021, then rose by 2.53% to $812.0 million in 2022, then grew by 7.88% to $876.0 million in 2023, then grew by 7.08% to $938.0 million in 2024, then increased by 4.69% to $982.0 million in 2025.
  • Its last three reported values are $982.0 million in Q3 2025, $890.0 million for Q2 2025, and $917.0 million during Q1 2025.